Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 397 to 401 of 401 entries
Sorted by: Best Match Show Resources per page
Publisher Correction: LifeTime and improving European healthcare through cell-based interceptive medicine.

Nature

Rajewsky N, Almouzni G, Gorski SA, Aerts S, Amit I, Bertero MG, Bock C, Bredenoord AL, Cavalli G, Chiocca S, Clevers H, De Strooper B, Eggert A, Ellenberg J, Fernández XM, Figlerowicz M, Gasser SM, Hubner N, Kjems J, Knoblich JA, Krabbe G, Lichter P, Linnarsson S, Marine JC, Marioni JC, Marti-Renom MA, Netea MG, Nickel D, Nollmann M, Novak HR, Parkinson H, Piccolo S, Pinheiro I, Pombo A, Popp C, Reik W, Roman-Roman S, Rosenstiel P, Schultze JL, Stegle O, Tanay A, Testa G, Thanos D, Theis FJ, Torres-Padilla ME, Valencia A, Vallot C, van Oudenaarden A, Vidal M, Voet T.
PMID: 33731935
Nature. 2021 Apr;592(7852):E8. doi: 10.1038/s41586-021-03287-8.

No abstract available.

Cite
Rajewsky N, Almouzni G, Gorski SA, et al. Publisher Correction: LifeTime and improving European healthcare through cell-based interceptive medicine. Nature. 2021;592(7852):E8doi: 10.1038/s41586-021-03287-8.
Rajewsky, N., Almouzni, G., Gorski, S. A., Aerts, S., Amit, I., Bertero, M. G., Bock, C., Bredenoord, A. L., Cavalli, G., Chiocca, S., Clevers, H., De Strooper, B., Eggert, A., Ellenberg, J., Fernández, X. M., Figlerowicz, M., Gasser, S. M., Hubner, N., Kjems, J., Knoblich, J. A., Krabbe, G., Lichter, P., Linnarsson, S., Marine, J. C., Marioni, J. C., Marti-Renom, M. A., Netea, M. G., Nickel, D., Nollmann, M., Novak, H. R., Parkinson, H., Piccolo, S., Pinheiro, I., Pombo, A., Popp, C., Reik, W., Roman-Roman, S., Rosenstiel, P., Schultze, J. L., Stegle, O., Tanay, A., Testa, G., Thanos, D., Theis, F. J., Torres-Padilla, M. E., Valencia, A., Vallot, C., van Oudenaarden, A., Vidal, M., Voet, T. (2021). Publisher Correction: LifeTime and improving European healthcare through cell-based interceptive medicine. Nature, 592(7852), E8. https://doi.org/10.1038/s41586-021-03287-8
Rajewsky, Nikolaus, et al. "Publisher Correction: LifeTime and improving European healthcare through cell-based interceptive medicine." Nature vol. 592,7852 (2021): E8. doi: https://doi.org/10.1038/s41586-021-03287-8
Rajewsky N, Almouzni G, Gorski SA, Aerts S, Amit I, Bertero MG, Bock C, Bredenoord AL, Cavalli G, Chiocca S, Clevers H, De Strooper B, Eggert A, Ellenberg J, Fernández XM, Figlerowicz M, Gasser SM, Hubner N, Kjems J, Knoblich JA, Krabbe G, Lichter P, Linnarsson S, Marine JC, Marioni JC, Marti-Renom MA, Netea MG, Nickel D, Nollmann M, Novak HR, Parkinson H, Piccolo S, Pinheiro I, Pombo A, Popp C, Reik W, Roman-Roman S, Rosenstiel P, Schultze JL, Stegle O, Tanay A, Testa G, Thanos D, Theis FJ, Torres-Padilla ME, Valencia A, Vallot C, van Oudenaarden A, Vidal M, Voet T. Publisher Correction: LifeTime and improving European healthcare through cell-based interceptive medicine. Nature. 2021 Apr;592(7852):E8. doi: 10.1038/s41586-021-03287-8. PMID: 33731935; PMCID: PMC8009763.
Copy Download .nbib Format: NLM
Do age, fitness, and concomitant medications influence management and outcomes of patients with CLL treated with ibrutinib?.

Blood advances

Tedeschi A, Frustaci AM, Mauro FR, Chiarenza A, Coscia M, Ciolli S, Reda G, Laurenti L, Varettoni M, Murru R, Baratè C, Sportoletti P, Greco A, Borella C, Rossi V, Deodato M, Biagi A, Zamprogna G, Pelle AC, Lapietra G, Vitale C, Morelli F, Cassin R, Fresa A, Cavalloni C, Postorino M, Ielo C, Cairoli R, Di Raimondo F, Montillo M, Del Poeta G.
PMID: 34525181
Blood Adv. 2021 Dec 28;5(24):5490-5500. doi: 10.1182/bloodadvances.2021004824.

Functional reserve of organs and systems is known to be relevant in predicting immunochemotherapy tolerance. Age and comorbidities, assessed by the cumulative illness rating scale (CIRS), have been used to address chemotherapy intensity. In the ibrutinib era, it is...

Cite
Tedeschi A, Frustaci AM, Mauro FR, et al. Do age, fitness, and concomitant medications influence management and outcomes of patients with CLL treated with ibrutinib?. Blood Adv. 2021;5(24):5490-5500doi: 10.1182/bloodadvances.2021004824.
Tedeschi, A., Frustaci, A. M., Mauro, F. R., Chiarenza, A., Coscia, M., Ciolli, S., Reda, G., Laurenti, L., Varettoni, M., Murru, R., Baratè, C., Sportoletti, P., Greco, A., Borella, C., Rossi, V., Deodato, M., Biagi, A., Zamprogna, G., Pelle, A. C., Lapietra, G., Vitale, C., Morelli, F., Cassin, R., Fresa, A., Cavalloni, C., Postorino, M., Ielo, C., Cairoli, R., Di Raimondo, F., Montillo, M., & Del Poeta, G. (2021). Do age, fitness, and concomitant medications influence management and outcomes of patients with CLL treated with ibrutinib?. Blood advances, 5(24), 5490-5500. https://doi.org/10.1182/bloodadvances.2021004824
Tedeschi, Alessandra, et al. "Do age, fitness, and concomitant medications influence management and outcomes of patients with CLL treated with ibrutinib?." Blood advances vol. 5,24 (2021): 5490-5500. doi: https://doi.org/10.1182/bloodadvances.2021004824
Tedeschi A, Frustaci AM, Mauro FR, Chiarenza A, Coscia M, Ciolli S, Reda G, Laurenti L, Varettoni M, Murru R, Baratè C, Sportoletti P, Greco A, Borella C, Rossi V, Deodato M, Biagi A, Zamprogna G, Pelle AC, Lapietra G, Vitale C, Morelli F, Cassin R, Fresa A, Cavalloni C, Postorino M, Ielo C, Cairoli R, Di Raimondo F, Montillo M, Del Poeta G. Do age, fitness, and concomitant medications influence management and outcomes of patients with CLL treated with ibrutinib?. Blood Adv. 2021 Dec 28;5(24):5490-5500. doi: 10.1182/bloodadvances.2021004824. PMID: 34525181.
Copy Download .nbib Format: NLM
Chronic Oral Administration of Mineral Oil Compared With Corn Oil: Effects on Gut Permeability and Plasma Inflammatory and Lipid Biomarkers.

Frontiers in pharmacology

Pieterman EJ, Princen HMG, Jarke A, Nilsson R, Cavallin A, Bergenholm L, Henricsson M, Gopaul VS, Agrawal R, Nissen SE, Hurt-Camejo E.
PMID: 34483899
Front Pharmacol. 2021 Aug 16;12:681455. doi: 10.3389/fphar.2021.681455. eCollection 2021.

We investigated the effects of chronic oral administration of mineral oil, versus corn oil as control, on intestinal permeability, inflammatory markers, and plasma lipids in APOE*3-Leiden.CETP mice. Mice received mineral oil or corn oil 15 or 30 μL/mouse/day for...

Cite
Pieterman EJ, Princen HMG, Jarke A, et al. Chronic Oral Administration of Mineral Oil Compared With Corn Oil: Effects on Gut Permeability and Plasma Inflammatory and Lipid Biomarkers. Front Pharmacol. 2021;12:681455doi: 10.3389/fphar.2021.681455.
Pieterman, E. J., Princen, H. M. G., Jarke, A., Nilsson, R., Cavallin, A., Bergenholm, L., Henricsson, M., Gopaul, V. S., Agrawal, R., Nissen, S. E., & Hurt-Camejo, E. (2021). Chronic Oral Administration of Mineral Oil Compared With Corn Oil: Effects on Gut Permeability and Plasma Inflammatory and Lipid Biomarkers. Frontiers in pharmacology, 12681455. https://doi.org/10.3389/fphar.2021.681455
Pieterman, Elsbet J, et al. "Chronic Oral Administration of Mineral Oil Compared With Corn Oil: Effects on Gut Permeability and Plasma Inflammatory and Lipid Biomarkers." Frontiers in pharmacology vol. 12 (2021): 681455. doi: https://doi.org/10.3389/fphar.2021.681455
Pieterman EJ, Princen HMG, Jarke A, Nilsson R, Cavallin A, Bergenholm L, Henricsson M, Gopaul VS, Agrawal R, Nissen SE, Hurt-Camejo E. Chronic Oral Administration of Mineral Oil Compared With Corn Oil: Effects on Gut Permeability and Plasma Inflammatory and Lipid Biomarkers. Front Pharmacol. 2021 Aug 16;12:681455. doi: 10.3389/fphar.2021.681455. eCollection 2021. PMID: 34483899; PMCID: PMC8415260.
Copy Download .nbib Format: NLM
Long-term outcomes after lung-sparing surgery for epithelial mesothelioma.

Journal of thoracic disease

Breda C, Furia S, Lucchini G, Zaccaria A, Verderi E, Natale G, Lo Giudice F, Cavallin R, Ferronato A, Fontana P.
PMID: 34992808
J Thorac Dis. 2021 Nov;13(11):6283-6293. doi: 10.21037/jtd-21-691.

BACKGROUND: This observational study evaluates retrospectively the long-term outcomes after pleurectomy/decortication for pleural mesothelioma, with and without the resection/reconstruction of diaphragm and pericardium.METHODS: Data from 155 consecutive patients undergoing lung-sparing surgery for epithelial pleural mesothelioma were reviewed. Selection criteria...

Cite
Breda C, Furia S, Lucchini G, et al. Long-term outcomes after lung-sparing surgery for epithelial mesothelioma. J Thorac Dis. 2021;13(11):6283-6293doi: 10.21037/jtd-21-691.
Breda, C., Furia, S., Lucchini, G., Zaccaria, A., Verderi, E., Natale, G., Lo Giudice, F., Cavallin, R., Ferronato, A., & Fontana, P. (2021). Long-term outcomes after lung-sparing surgery for epithelial mesothelioma. Journal of thoracic disease, 13(11), 6283-6293. https://doi.org/10.21037/jtd-21-691
Breda, Cristiano, et al. "Long-term outcomes after lung-sparing surgery for epithelial mesothelioma." Journal of thoracic disease vol. 13,11 (2021): 6283-6293. doi: https://doi.org/10.21037/jtd-21-691
Breda C, Furia S, Lucchini G, Zaccaria A, Verderi E, Natale G, Lo Giudice F, Cavallin R, Ferronato A, Fontana P. Long-term outcomes after lung-sparing surgery for epithelial mesothelioma. J Thorac Dis. 2021 Nov;13(11):6283-6293. doi: 10.21037/jtd-21-691. PMID: 34992808; PMCID: PMC8662484.
Copy Download .nbib Format: NLM
Midwives' Evaluation of a Neonatal Resuscitation in High- and Low-Resource Settings.

Frontiers in pediatrics

Cavallin F, Calgaro S, Borellini M, Magnani M, Beltramini G, Seni AHA, Cebola BR, Tambo AN, Putoto G, Trevisanuto D.
PMID: 33768084
Front Pediatr. 2021 Mar 09;9:644308. doi: 10.3389/fped.2021.644308. eCollection 2021.

No abstract available.

Cite
Cavallin F, Calgaro S, Borellini M, et al. Midwives' Evaluation of a Neonatal Resuscitation in High- and Low-Resource Settings. Front Pediatr. 2021;9:644308doi: 10.3389/fped.2021.644308.
Cavallin, F., Calgaro, S., Borellini, M., Magnani, M., Beltramini, G., Seni, A. H. A., Cebola, B. R., Tambo, A. N., Putoto, G., & Trevisanuto, D. (2021). Midwives' Evaluation of a Neonatal Resuscitation in High- and Low-Resource Settings. Frontiers in pediatrics, 9644308. https://doi.org/10.3389/fped.2021.644308
Cavallin, Francesco, et al. "Midwives' Evaluation of a Neonatal Resuscitation in High- and Low-Resource Settings." Frontiers in pediatrics vol. 9 (2021): 644308. doi: https://doi.org/10.3389/fped.2021.644308
Cavallin F, Calgaro S, Borellini M, Magnani M, Beltramini G, Seni AHA, Cebola BR, Tambo AN, Putoto G, Trevisanuto D. Midwives' Evaluation of a Neonatal Resuscitation in High- and Low-Resource Settings. Front Pediatr. 2021 Mar 09;9:644308. doi: 10.3389/fped.2021.644308. eCollection 2021. PMID: 33768084; PMCID: PMC7985172.
Copy Download .nbib Format: NLM
Showing 397 to 401 of 401 entries